Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Brenner

Showing results (241-250 of 298) with videos related to

Pageof 30
Sort By:
Nature Communications|July 22, 2014
GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosisInmaculada Lopez-Sanchez, Ying Dunkel, Yoon-Seok Roh, et al.
Gastroenterology|January 27, 2020
Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis ResolutionXiao Liu, Jun Xu, Sara Rosenthal, et al.
Nature Immunology|September 18, 2012
Monocytes-macrophages that express α-smooth muscle actin preserve primitive hematopoietic cells in the bone marrowAya Ludin, Tomer Itkin, Shiri Gur-Cohen, et al.
Science (New York, N.Y.)|July 17, 2012
Identification of small molecule activators of cryptochromeTsuyoshi Hirota, Jae Wook Lee, Peter C St John, et al.
Hepatology Communications|January 6, 2025
Serum amyloid P (PTX2) attenuates hepatic fibrosis in mice by inhibiting the activation of fibrocytes and HSCsMin Cong, Raquel Carvalho Gontijo Weber, Sadatsugu Sakane, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 12, 2026
Msln/Muc16 signaling in activated Portal Fibroblasts drives the development of cholestatic fibrosis and HCC in aged female Mdr2<sup>-/-</sup> miceSadatsugu Sakane, Takahiro Nishio, Hiroaki Fuji, et al.
Journal of Hepatology|May 10, 2019
Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout miceTakahiro Nishio, Ronglin Hu, Yukinori Koyama, et al.
Hepatology (Baltimore, Md.)|March 25, 2018
Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLDCyrielle Caussy, Cynthia Hsu, Min-Tzu Lo, et al.
Gut|December 21, 2018
Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver diseaseCyrielle Caussy, Veeral H Ajmera, Puneet Puri, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 1, 2021
Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western DietSouradipta Ganguly, German Aleman Muench, Linshan Shang, et al.
Pageof 30

Showing results (241-250 of 298) with videos related to

Sort By:
Pageof 30
Nature Communications|July 22, 2014
GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosisInmaculada Lopez-Sanchez, Ying Dunkel, Yoon-Seok Roh, et al.
Gastroenterology|January 27, 2020
Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis ResolutionXiao Liu, Jun Xu, Sara Rosenthal, et al.
Nature Immunology|September 18, 2012
Monocytes-macrophages that express α-smooth muscle actin preserve primitive hematopoietic cells in the bone marrowAya Ludin, Tomer Itkin, Shiri Gur-Cohen, et al.
Science (New York, N.Y.)|July 17, 2012
Identification of small molecule activators of cryptochromeTsuyoshi Hirota, Jae Wook Lee, Peter C St John, et al.
Hepatology Communications|January 6, 2025
Serum amyloid P (PTX2) attenuates hepatic fibrosis in mice by inhibiting the activation of fibrocytes and HSCsMin Cong, Raquel Carvalho Gontijo Weber, Sadatsugu Sakane, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 12, 2026
Msln/Muc16 signaling in activated Portal Fibroblasts drives the development of cholestatic fibrosis and HCC in aged female Mdr2<sup>-/-</sup> miceSadatsugu Sakane, Takahiro Nishio, Hiroaki Fuji, et al.
Journal of Hepatology|May 10, 2019
Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout miceTakahiro Nishio, Ronglin Hu, Yukinori Koyama, et al.
Hepatology (Baltimore, Md.)|March 25, 2018
Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLDCyrielle Caussy, Cynthia Hsu, Min-Tzu Lo, et al.
Gut|December 21, 2018
Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver diseaseCyrielle Caussy, Veeral H Ajmera, Puneet Puri, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 1, 2021
Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western DietSouradipta Ganguly, German Aleman Muench, Linshan Shang, et al.
Pageof 30